ACS report: “Alarming” health disparities in preventable cancers persist as overall cancer mortality continues to fall

WHO projects new cancer cases will rise to 35 million by 2050 globally

In a new report, the World Health Organization called for urgent action to address cancer, projecting that new cases will rise to nearly 35 million by 2050.

July 31, 2026

Vol.52 No.30

Podcast The Directors

The Directors: Two leaders in data science have a warp speed vision for AI, with cancer clinical trials leading the way
Knudsen and Thoelke: “It’s actually solving for bottlenecks and challenges that we’ve been unable to overcome for so long”

The United States has a translation problem. Scientific breakthroughs in oncology are accelerating, but clinical trial infrastructure hasn’t kept pace.

July 17, 2026

Vol.52 No.28

By Paul Goldberg and Claire Marie Porter

Guest Editorial

Cancer progress is not reaching everyone. Native Nations must be part of the solution.

In 1971, the National Cancer Act set the United States on a path to confront one of its most formidable public health challenges. More than five decades later, the progress is undeniable. The latest 2026 report from the American Cancer Society shows continued declines in overall cancer mortality and improvements in survival for many major cancer types. Recent advances in early detection, prevention, and treatment are saving lives.

Cancer patients with Medicare Advantage have access to fewer providers than Medicare patients, cross-sectional study finds

Medicare Advantage beneficiaries have access to fewer cancer specialists, when compared to traditional Medicare beneficiaries, according to a study published in JAMA Network Open.

Equal access to cancer care removes race as predictor of survival, VA analysis finds

A healthcare system designed to provide more consistent access to comprehensive multidisciplinary cancer care can help eliminate longstanding racial gaps in cancer survival in the United States, according to a study led by a UCLA-VA collaborative team.

July 10, 2026

Vol.52 No.27

Clinical Roundup

Sexual orientation, gender identity are key variables in cancer screening disparities, OSUCCC – James study finds

Research has uncovered persistent disparities in preventive cancer care across different sexual orientation and gender identity populations. The study, conducted by researchers at The Ohio State University Wexner Medical Center and The James Comprehensive Cancer Center, found particular concern for cervical and breast cancer screening.

July 10, 2026

Vol.52 No.27

ACS report: “Alarming” health disparities in preventable cancers persist as overall cancer mortality continues to fall

YOU MAY BE INTERESTED IN

WHO projects new cancer cases will rise to 35 million by 2050 globally

The Directors: Two leaders in data science have a warp speed vision for AI, with cancer clinical trials leading the way
Knudsen and Thoelke: “It’s actually solving for bottlenecks and challenges that we’ve been unable to overcome for so long”

Cancer progress is not reaching everyone. Native Nations must be part of the solution.

Cancer patients with Medicare Advantage have access to fewer providers than Medicare patients, cross-sectional study finds

Equal access to cancer care removes race as predictor of survival, VA analysis finds

Sexual orientation, gender identity are key variables in cancer screening disparities, OSUCCC – James study finds

Renew today!

Subscriber content

Never miss an issue!

Login

ACS report: “Alarming” health disparities in preventable cancers persist as overall cancer mortality continues to fall

YOU MAY BE INTERESTED IN

WHO projects new cancer cases will rise to 35 million by 2050 globally

The Directors: Two leaders in data science have a warp speed vision for AI, with cancer clinical trials leading the wayKnudsen and Thoelke: “It’s actually solving for bottlenecks and challenges that we’ve been unable to overcome for so long”

Cancer progress is not reaching everyone. Native Nations must be part of the solution.

Cancer patients with Medicare Advantage have access to fewer providers than Medicare patients, cross-sectional study finds

Equal access to cancer care removes race as predictor of survival, VA analysis finds

Sexual orientation, gender identity are key variables in cancer screening disparities, OSUCCC – James study finds

Never miss an issue!

Login

The Directors: Two leaders in data science have a warp speed vision for AI, with cancer clinical trials leading the way
Knudsen and Thoelke: “It’s actually solving for bottlenecks and challenges that we’ve been unable to overcome for so long”